Literature DB >> 22432415

Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA.

Ajitha Thanabalasuriar1, Julien Bergeron, Akira Gillingham, Mark Mimee, Jenny-Lee Thomassin, Nathalie Strynadka, Jinoh Kim, Samantha Gruenheid.   

Abstract

Enteropathogenic and enterohaemorrhagic Escherichia coli (EPEC and EHEC) are food-borne pathogens that cause severe diarrhoeal disease in humans. Citrobacter rodentium is a related mouse pathogen that serves as a small animal model for EPEC and EHEC infections. EPEC, EHEC and C. rodentium translocate bacterial virulence proteins directly into host cells via a type III secretion system (T3SS). Non-LEE-encoded effector A (NleA) is a T3SS effector that is common to EPEC, EHEC and C. rodentium and is required for bacterial virulence. NleA localizes to the host cell secretory pathway and inhibits vesicle trafficking by interacting with the Sec24 subunit of mammalian coatamer protein II complex (COPII). Mammalian cells express four paralogues of Sec24 (Sec24A-D), which mediate selection of cargo proteins for transport and possess distinct, but overlapping cargo specificities. Here, we show that NleA binds Sec24A-D with two distinct mechanisms. An NleA protein variant with greatly diminished interaction with all Sec24 paralogues does not properly localize, does not inhibit COPII-mediated vesicle budding, and does not confer virulence in the mouse infection model. Together, this work provides strong evidence that the interaction and inhibition of COPII by NleA is an important aspect of EPEC- and EHEC-mediated disease.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22432415     DOI: 10.1111/j.1462-5822.2012.01789.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  8 in total

Review 1.  Bacteria fighting back: how pathogens target and subvert the host innate immune system.

Authors:  L Evan Reddick; Neal M Alto
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

Review 2.  Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins.

Authors:  Xiaonan Zhuang; Zijuan Chen; Chenxi He; Lin Wang; Ruixue Zhou; Dapeng Yan; Baoxue Ge
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

3.  The Salmonella transmembrane effector SteD hijacks AP1-mediated vesicular trafficking for delivery to antigen-loading MHCII compartments.

Authors:  Camilla Godlee; Ondrej Cerny; Mei Liu; Samkeliso Blundell; Alanna E Gallagher; Meriam Shahin; David W Holden
Journal:  PLoS Pathog       Date:  2022-05-27       Impact factor: 7.464

Review 4.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 5.  Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.

Authors:  Paul Ugalde-Silva; Octavio Gonzalez-Lugo; Fernando Navarro-Garcia
Journal:  Front Cell Infect Microbiol       Date:  2016-08-24       Impact factor: 5.293

6.  CteG is a Chlamydia trachomatis effector protein that associates with the Golgi complex of infected host cells.

Authors:  Sara V Pais; Charlotte E Key; Vítor Borges; Inês S Pereira; João Paulo Gomes; Derek J Fisher; Luís Jaime Mota
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

7.  EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals.

Authors:  Xue Xia; Yue Liu; Andrea Hodgson; Dongqing Xu; Wenxuan Guo; Hongbing Yu; Weifeng She; Chenxing Zhou; Lei Lan; Kai Fu; Bruce A Vallance; Fengyi Wan
Journal:  PLoS Pathog       Date:  2019-06-28       Impact factor: 6.823

8.  Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation.

Authors:  Hilo Yen; Nakaba Sugimoto; Toru Tobe
Journal:  PLoS Pathog       Date:  2015-09-02       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.